The global portable bioprocessing bioreactors market is witnessing rapid growth, valued at USD 2.95 billion in 2024 and projected to surge to USD 7.25 billion by 2034 at a CAGR of 9.37% (2025-2034).
This expansion is fueled by the increasing demand for flexible and scalable biomanufacturing systems suitable for biologics, cell and gene therapies, and personalized medicines. Key drivers include technological advancements such as automation and single-use technologies, and the rise of CDMOs and biomanufacturing expansion in emerging economies.
Key Market Insights
-
Market Size (2024): USD 2.95 billion
-
Projected Size (2034): USD 7.25 billion
-
CAGR (2025–2034): 9.37%
-
Leading Region: North America (31.5% revenue share in 2024)
-
Fastest-Growing Region: Asia-Pacific
-
Top Segment (System Type): Single-use portable bioreactors (41% share)
-
Top Segment (Capacity): 1-10L
Leading Companies in the Portable Bioprocessing Bioreactors Market
1. Thermo Fisher Scientific
About: A global leader in scientific services, Thermo Fisher specializes in laboratory and bioprocessing solutions.
Products: HyPerforma single-use bioreactors, fermenters, and process monitoring systems.
Market Cap: Approx. USD 190 billion.
2. Sartorius AG
About: Sartorius focuses on bioprocessing and lab equipment, driving innovations in single-use technologies.
Products: Ambr and BIOSTAT series bioreactors, filtration systems.
Market Cap: Approx. USD 30 billion.
3. Merck KGaA
About: A prominent science and technology company, Merck is at the forefront of bioprocessing advancements.
Products: Mobius single-use bioreactors, bioprocessing hardware, and consumables.
Market Cap: Approx. USD 95 billion.
4. Eppendorf AG
About: Known for lab automation and bioreactor technologies, Eppendorf supports scalable biomanufacturing.
Products: BioFlo bioreactors, fermenters, and cell culture solutions.
Market Cap: Private company; estimated revenues exceed USD 1 billion.
5. Danaher Corporation
About: Danaher’s diverse portfolio includes life sciences and diagnostics, supporting global bioprocessing demand.
Products: Pall and Cytiva bioprocessing systems.
Market Cap: Approx. USD 200 billion.
6. GE Healthcare (Cytiva)
About: A key player in healthcare technologies, GE’s Cytiva division leads in bioprocessing equipment.
Products: Xcellerex single-use bioreactors and FlexFactory solutions.
Market Cap: Approx. USD 30 billion (Cytiva as part of Danaher).
7. IKA Labortechnik
About: Specializes in laboratory and analytical equipment with a growing presence in bioprocessing.
Products: Bioreactors, fermenters, and mixing systems.
Market Cap: Private company.
8. Biosan
About: A niche provider of lab and bioprocessing equipment with a focus on compact systems.
Products: Bench-top bioreactors and cell culture devices.
Market Cap: Private company.
9. PBS Biotech
About: Innovator in single-use bioreactors for advanced cell therapy manufacturing.
Products: Vertical-Wheel bioreactors.
Market Cap: Private company.
10. Pall Corporation
About: Part of Danaher, Pall offers a wide range of bioprocessing solutions.
Products: Single-use systems, filtration devices.
Market Cap: Integrated within Danaher.
11. Solaris Biotech
About: Known for compact and portable bioprocessing solutions tailored for research and industry.
Products: Genesis and Jupiter bioreactor lines.
Market Cap: Private company.
12. Applikon Biotechnology
About: Focuses on advanced bioreactor systems for R&D and production.
Products: Applikon BIOSTAT and EZ-Control bioreactors.
Market Cap: Part of Getinge Group.
13. Distek Inc.
About: Offers bioprocessing solutions for pharmaceutical and biotechnology applications.
Products: BIOne single-use bioreactors and accessories.
Market Cap: Private company.
14. Parker Hannifin Corporation
About: Specializes in motion and control technologies with applications in bioprocessing.
Products: Bioprocess filtration and control systems.
Market Cap: Approx. USD 55 billion.
15. Avantor Fluid Handling LLC
About: Delivers materials and consumables for biopharma manufacturing.
Products: Bioprocess tubing, connectors, and single-use assemblies.
Market Cap: Approx. USD 18 billion.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
FAQs about the Portable Bioprocessing Bioreactors Market
1. What is driving the growth of the portable bioprocessing bioreactors market?
The demand for flexible and scalable solutions in biologics, cell therapies, and personalized medicine is fueling market growth.
2. Which region is the largest market for portable bioprocessing bioreactors?
North America holds the largest market share, accounting for 31.5% of revenue in 2024.
3. What are the advantages of single-use portable bioreactors?
They reduce contamination risks, lower operational costs, and support rapid process scale-up.
4. Who are the leading players in this market?
Top companies include Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Danaher Corporation, and GE Healthcare.
5. What is the expected CAGR for this market?
The market is projected to grow at a CAGR of 9.37% between 2025 and 2034.
Source : https://www.towardshealthcare.com/insights/portable-bioprocessing-bioreactors-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5855
About the Author
